Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Continental Chemicals Ltd has submitted to BSE the newspaper clippings of its unaudited financial results for Q2 FY26 and half-year ended 30 September 2025, filed under Regulation 47 of SEBI LODR. Revenue from operations for the quarter stood at Rs 8,072 lakhs, up from Rs 7,576 lakhs in the year-ago quarter. Net profit after tax for Q2 FY26 came in at Rs 297 lakhs, a sharp jump from just Rs 13 lakhs in Q2 FY25. Total comprehensive income for the quarter was Rs 376 lakhs, while basic and diluted EPS stood at Rs 0.51 versus Rs 0.43 a year earlier. For the half-year (H1 FY26), revenue reached Rs 16,738 lakhs compared with Rs 15,101 lakhs in H1 FY25, showing healthy top-line growth. The results were reviewed by the audit committee and approved by the board on 13 November 2025.
Strong year-on-year profit growth in Q2 despite a modest revenue rise points to margin improvement, which is a positive signal for shareholders. However, Continental Chemicals is a small-cap company with limited float, so the immediate impact on stock price may be muted pending investor reaction to the full results.